Q4 2024 Earnings Call Transcript February 28, 2025 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.31. Operator: Greetings, and welcome to the Fulgent ...

Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from FY... EL MONTE, Calif., February 28, 2025--Fulgent Genetics, Inc. (NASDAQ ...

Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.

UBS analyst Dan Leonard lowered the firm’s price target on Fulgent Genetics (FLGT) to $20 from $27 and keeps a Neutral rating on the shares.

Piper Sandler analyst David Westenberg lowered the firm’s price target on Fulgent Genetics (FLGT) to $16 from $22 following quarterly results.

Fulgent Genetics (($FLGT)) has held its Q4 earnings call. Read on for the main highlights of the call. Fulgent Genetics’ recent earnings call ...

Proficio Capital Partners LLC bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the ...

NASDAQ FLGT opened at $18.59 on Wednesday. Fulgent Genetics has a 52-week low of $14.57 and a 52-week high of $25.11. The company has a 50-day simple moving average of $17.14 and a 200 day simple ...

Discover the top 5 undervalued Health Care Providers & Services stocks for Wednesday, March 12 based on AAII’s Stock Grades.

FULGENT GENETICS ($FLGT) posted quarterly earnings results on Friday, February 28th. The company reported earnings of $0.04 per share, beating estimates of -$0.13 by ...

Greetings and welcome to the Fulgent Genetics Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions]. A question-and-answer session ...

Please go ahead. Thanks, Kevin. Good morning, and welcome to the Fulgent's fourth-quarter and full-year 2024 financial results conference call. On the call today are Ming Hsieh, Chief Executive ...